Company intelligence / Profile preview

Darst Capital, Inc.

New York, New York, United Statesdarstcapital.com ↗

Ownership: Private
Development stage: Phase 3

Overview

Darst Capital, Inc. is an investment or asset management firm. There is no evidence it operates in the life sciences or healthcare sector. The president is David Darst[8], who has extensive experience in finance and investment strategy but whose professional background does include some involvement with biotech investments through other entities[1]. No clinical programs or therapeutic pipeline are associated with this entity.

Industry: Investors

Drug pipeline

3 assets

ompenaclid

Phase 3

Indications: Cancer

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Darst Capital, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Darst Capital, Inc..

Explore the full profile